Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin and Sunlight for Myopia Progression in Children
NCT03552016Phase 2Withdrawn
- Sponsor
- University of Missouri
- Start
- Oct 2018
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of riboflavin in myopia, sponsored by University of Missouri. Planned start Oct 2018; status: withdrawn.
02
Drugs
riboflavin
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03552016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03552016.